David W. Cescon
机构:University Health Network, University of Toronto, Toronto Rehabilitation Institute, Princess Margaret Cancer Centre, Princess Margaret Hospital · ORCID:0000-0002-1080-0998
发表论文 430 篇 · 总被引 15253 次 · h-index 56
代表论文
- KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy (2025 · Clinical Cancer Research · 被引 1)
- The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer (2025 · npj Breast Cancer · 被引 1)
- A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer (2026 · Nature Communications)
- Supplementary Figure 4 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer (2026)
- Supplementary Table 3 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer (2026)
- Supplementary Table 7 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer (2026)